Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8562465rdf:typepubmed:Citationlld:pubmed
pubmed-article:8562465lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8562465lifeskim:mentionsumls-concept:C0010068lld:lifeskim
pubmed-article:8562465lifeskim:mentionsumls-concept:C0033144lld:lifeskim
pubmed-article:8562465lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8562465pubmed:dateCreated1996-3-7lld:pubmed
pubmed-article:8562465pubmed:abstractTextSymptomatic treatment of patients with angina pectoris is well established and consists of nitrates, calcium antagonists, or beta-blockers. All these drugs improve symptomatology and reduce signs of ischemia on exercise test or long-term electrocardiogram recordings. It is not known, however, whether these drugs also improve prognosis. The only drug shown to improve prognosis is aspirin. In order to study the prognostic effect of calcium antagonists and beta-blockers, these two drugs were compared in the APSIS study.lld:pubmed
pubmed-article:8562465pubmed:languageenglld:pubmed
pubmed-article:8562465pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8562465pubmed:citationSubsetIMlld:pubmed
pubmed-article:8562465pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8562465pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8562465pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8562465pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8562465pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8562465pubmed:statusMEDLINElld:pubmed
pubmed-article:8562465pubmed:monthAuglld:pubmed
pubmed-article:8562465pubmed:issn0920-3206lld:pubmed
pubmed-article:8562465pubmed:authorpubmed-author:HjemdahlPPlld:pubmed
pubmed-article:8562465pubmed:authorpubmed-author:ForslundLLlld:pubmed
pubmed-article:8562465pubmed:authorpubmed-author:HellKKlld:pubmed
pubmed-article:8562465pubmed:authorpubmed-author:RehnqvistNNlld:pubmed
pubmed-article:8562465pubmed:authorpubmed-author:BillingEElld:pubmed
pubmed-article:8562465pubmed:authorpubmed-author:ErikssonS VSVlld:pubmed
pubmed-article:8562465pubmed:authorpubmed-author:BjörkanderIIlld:pubmed
pubmed-article:8562465pubmed:authorpubmed-author:WallénHHlld:pubmed
pubmed-article:8562465pubmed:issnTypePrintlld:pubmed
pubmed-article:8562465pubmed:volume9 Suppl 3lld:pubmed
pubmed-article:8562465pubmed:ownerNLMlld:pubmed
pubmed-article:8562465pubmed:authorsCompleteYlld:pubmed
pubmed-article:8562465pubmed:pagination493lld:pubmed
pubmed-article:8562465pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:meshHeadingpubmed-meshheading:8562465-...lld:pubmed
pubmed-article:8562465pubmed:year1995lld:pubmed
pubmed-article:8562465pubmed:articleTitlePrimary prevention in patients with coronary heart disease: the APSIS study.lld:pubmed
pubmed-article:8562465pubmed:affiliationDepartment of Medicine, Danderyd Hospital, Sweden.lld:pubmed
pubmed-article:8562465pubmed:publicationTypeJournal Articlelld:pubmed